Drugs / Madopar Tab. 125 or Perkin Tab. 25-100mg
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04821687 Comparator | Jun 2021 → Aug 2022 | Parkinson disease | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Madopar Tab. 125 or Perkin Tab. 25-100mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04821687 ↗ |